{"name":"UCB Celltech","slug":"ucb-celltech","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"UCB4940 560 mg","genericName":"UCB4940 560 mg","slug":"ucb4940-560-mg","indication":"Other","status":"phase_1"},{"name":"UCB7665 Intravenous 3","genericName":"UCB7665 Intravenous 3","slug":"ucb7665-intravenous-3","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"UCB4940 560 mg","genericName":"UCB4940 560 mg","slug":"ucb4940-560-mg","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"UCB7665 Intravenous 3","genericName":"UCB7665 Intravenous 3","slug":"ucb7665-intravenous-3","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxPbnNqTXZGU0gxMmpDUklLSHI1ZlVYdlZ5Rk9KSHhSXy1KbVQ5NWFiUy1TbWVFN2x6cTE0dGNkbmwxSmVBSU5rZjIyajZxaTA3TC1Icm13aVlqMVBELXoyblBhX3RobTdvSkhvX1pMbVJOYkdobU5xd2FKTW83bzRGdHZ6cGZ0ak9ySHhiWEw1MWhxYUxDenQyMjV5c1h6Tk1QalNhblAyOE5zeE5NTXpfM0x0VUxldVlBbEdtcklRczdLMFFJNU9KUDI1alF4NXhZZjhGa213emZDRlYycm1V?oc=5","date":"2026-03-02","type":"patent","source":"Morningstar","summary":"No-Moat UCB Focuses on Commercial Launches and Portfolio Diversification Amid Generic Pressure - Morningstar","headline":"No-Moat UCB Focuses on Commercial Launches and Portfolio Diversification Amid Generic Pressure","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxNNXptT2N4SmJTUy04X0F5MHN6NzktRFFiWFZ1UGN0MVhOdWFuYjdkYXp5alM1ckFlTUI3VlNhRVhPcnNLd29yNmsyZnBoLUIwSjYyOFQyMkctZ0MxNV9QSVQ4YzJkb0xDQVEtVEhjWmVSMElfbnFlQ0hmYm85SnJwazFUM2YwZkhtbGtSUmpjT2tsTUh5a09tekx4eVlTQ0tzckVGWlF5ZDFiQURRd0lVbjBGMkE3aXpwMThod0VIcw?oc=5","date":"2025-10-06","type":"regulatory","source":"Fierce Biotech","summary":"3 immunologists win Nobel Prize in Physiology or Medicine for discovery of regulatory T cells - Fierce Biotech","headline":"3 immunologists win Nobel Prize in Physiology or Medicine for discovery of regulatory T cells","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxORk4yZmxKeGxocXEtS3phb3BJVmtVcXBabGc2WGlfOFVpLVhIWTdQOTF0Z09VOUpWZUl1WUhaR0lNZlVqNUdlRUdwcE5yNUxrVm5HMjFKR256Vy1ndnBWY05tejFzSF9FRUJlUE1yeFFjWklkcE1uRWdkLXhRUHN0TWV3?oc=5","date":"2022-07-28","type":"pipeline","source":"bath.ac.uk","summary":"Dr Alastair D G Lawson: oration - bath.ac.uk","headline":"Dr Alastair D G Lawson: oration","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxOSVBuOEZyVXpTd2VlZUF1VFNNTjlUMlRpTFI3ejM2YjVCZEJOdkpIZnFONjR1SjBWaEMyNlBCSDJfY1UzU244dWtkOXJvSFY2djNydzh6SGpfX0prV3h6U3BnLTVYUkxGd0NqNmdlcHNuVUoyTm56ZWh1Y3JKTEF4NVpHUDU3cFhVd2JOT1B4V1ItTmhB?oc=5","date":"2018-12-05","type":"pipeline","source":"pharmaphorum","summary":"UCB, Roche, and IQVIA take lead in UK life sciences investment - pharmaphorum","headline":"UCB, Roche, and IQVIA take lead in UK life sciences investment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxPbEZORGlFTG9hNk1KU0RpOXZPSlpxclVzWEpTenM4U0ZDeEZMdGVIYUE3WmljWkFEdEFyR1VOMlRTN2VGaW9fR18ydVpBWWRfUEtmUWRYemd3MERUWFpjU0xtTHY3TExweVZkU0JlZkxnREtDR2c0MndZc1pZdjZlVE5wbw?oc=5","date":"2015-02-26","type":"deal","source":"Genetic Engineering and Biotechnology News","summary":"JSR Group and Partners Acquire KBI Biopharma - Genetic Engineering and Biotechnology News","headline":"JSR Group and Partners Acquire KBI Biopharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxQZno4UEFaOVRyR1daV2RISnBlb3RncHd3bUVjbDhsUkdDMGlCeHFvLVdJT2o4TGNEZ053REVpcWhkRzliMDg3VVNITTVhQVlVdFBFWkpHeGZUbS1LTkR2MHNqcnFFcjF5aWk4aFk1SFZSUTNQaGFCRFdBSTdxUGlHekRRTHZPMXhuMVdIZGRJSzR3WldNZ1BoWXlTbGlhOWZsUXdpby1pN0t5dw?oc=5","date":"2014-08-30","type":"deal","source":"The Guardian","summary":"As battle over AstraZeneca looms, one lab in Slough shows mergers can work - The Guardian","headline":"As battle over AstraZeneca looms, one lab in Slough shows mergers can work","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNelJMYWdMdkJsMEtNY3VVcElKUzhEX0haM2RvU0VUZEU1YWt6VXhzSjZhZ1BnMDRXT3RyLVpmNUtxb2l1QkZ6bmVTVERkUkFLU0haVThiM0dPVmpGSXYwSi02TWtWM09GOUlPcFFWZWNOTjNLM2VsOEdjVFRaRXNYVlhsdEQ5ajdTZWZ6SkR6NHZJcDlaZmFJ?oc=5","date":"2014-06-02","type":"pipeline","source":"BioSpectrum Asia","summary":"Novartis appoints a new oncology president - BioSpectrum Asia","headline":"Novartis appoints a new oncology president","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxNV3M3dHNMaUp1elpkQ0E3OUVmemlNTk81dmNJbVowSzVQVmRoTm5UUU5WNmppTEFyY2RDYVNXM0pqWDJYYk1oZEg0MWV3NDc5T3ZBOS02THRuZ2JXN2hTVEZCUXhYZ1NFeF9mSmo3bmlPb2hZTmVLZklIMXZ0TVIyamEybjhtUnMtVlkySmpn?oc=5","date":"2011-03-09","type":"pipeline","source":"PMLiVE","summary":"Interview with Roch Doliveux, UCB - PMLiVE","headline":"Interview with Roch Doliveux, UCB","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE9vWnZNb1R0aERyWmY5VnZPb1FaTldjTUJHT3VjUGJ5bkhBc3o5c0pNUWFwdkktWlo2Mm5LY2VNOEJXek9KcnYzN0drR2p5ZUVsNDhWYTR1bDBpMXgwY2puWkw0WDNiTHhBRnpjVThzRlY1a19CN1E?oc=5","date":"2006-09-26","type":"deal","source":"Pharmafile","summary":"UCB to buy Schwarz Pharma for 4 billion euros - Pharmafile","headline":"UCB to buy Schwarz Pharma for 4 billion euros","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxOcFY4aTRQa3NidlZlenpjWWJVV2xhNHJ2RzJHZVhCLVhOamE3NXN0VEFCbXZvdTBRaDVnVUZhT2ViMlpSNnNiblptbVgyejNKV1dteFJPUmtCbkV6ZktpQ0N5bUR0UUR2Y0pmTVF4cVhDOURibFlLekhNRWc0Zk9sOXJFZnVyZmVld0xKcjJUMnZjVzJyakE?oc=5","date":"2004-07-11","type":"pipeline","source":"The Pharma Letter","summary":"All conditions under UCB's offer for Celltech have been met - The Pharma Letter","headline":"All conditions under UCB's offer for Celltech have been met","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTE5tZk1VeVAwZmZ2bFFEelV2QUFYR3J4b09FaW9VU211ZjJXc0E5T3BVaWRRcVJheFZ4VTQ1emdHZ0w1dFF1WTFJdDZYcEhyM1Qwc2hyS013?oc=5","date":"2004-06-21","type":"pipeline","source":"Nature","summary":"Celltech acquisition sends mixed messages - Nature","headline":"Celltech acquisition sends mixed messages","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_1":2},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}